Journal Mobile Options
Table of Contents
Vol. 24, No. 3, 2007
Issue release date: August 2007
Dement Geriatr Cogn Disord 2007;24:177–184

Subjective Memory Complaints: Presence, Severity and Future Outcome in Normal Older Subjects

Glodzik-Sobanska L. · Reisberg B. · De Santi S. · Babb J.S. · Pirraglia E. · Rich K.E. · Brys M. · de Leon M.J.
aCenter for Brain Health, bDepartment of Psychiatry and cSilberstein Aging and Dementia Research Center, New York University School of Medicine, and dDepartment of Radiology, New York University Medical Center, New York, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: Subjective memory complaint (SMC) in normal individuals may predict future cognitive decline. The goal of this study was to examine whether the probability of decline increases with growing intensity of complaint. Methods: Normal subjects over the age of 50 years were included in a longitudinal retrospective study (mean follow-up time = 8 years). All subjects (n = 230) underwent cognitive and medical examination at baseline. The presence of SMC was determined based on Global Deterioration Scale staging. A subgroup of 83 participants also received baseline assessment for the intensity of SMC. Logistic regression was used to predict outcome from baseline variables. Three outcome groups were established at the final visit: nondeclining, declining and diagnostically unstable (i.e. the diagnosis changed over time: from normal to mild cognitive impairment, then back to normal). Results: The presence of SMC was a predictor of future decline but also increased the likelihood of the unstable diagnosis. Increasing intensity of SMC did not further raise the risk for decline. High intensity of complaints and more pronounced affective symptoms predicted the unstable clinical diagnosis. Conclusions: The presence of SMC contributes to the risk of future decline, however, the increasing intensity of the perceived impairment does not further enhance the risk.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Jorm AF, Butterworth P, Anstey KJ, et al: Memory complaints in a community sample aged 60–64 years: associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities. Psychol Med 2006;34:1495–1506.

    External Resources

  2. Blazer DG, Hays JC, Fillenbaum GG, Gold DT: Memory complaint as a predictor of cognitive decline: a comparison of African American and White elders. J Aging Health 1997;9:171–184.
  3. Clarnette RM, Almeida OP, Forstl H, Paton A, Martins RN: Clinical characteristics of individuals with subjective memory loss in Western Australia: results from a cross-sectional survey. Int J Geriatr Psychiatry 2001;16:168–174.
  4. Geerlings MI, Jonker C, Bouter LM, Ader HJ, Schmand B: Association between memory complaints and incident Alzheimer’s disease in elderly people with normal baseline cognition. Am J Psychiatry 1999;156:531–537.
  5. Derouesne C, Lacomblez L, Thibault S, LePoncin Lafitte M: Memory complaints in young and elderly subjects. Int J Geriatr Psychiatry 1999;14:291–301.
  6. Commissaris CJAM, Ponds RWHM, Jolles J: Subjective forgetfulness in a normal Dutch population: possibilities for health education and other interventions. Patient Educ Couns 1998;34:25–32.
  7. Hanninen T, Reinikainen KJ, Helkala EL, et al: Subjective memory complaints and personality traits in normal elderly subjects. J Am Geriatr Soc 1994;42:1–4.
  8. Pearman A, Storandt M: Predictors of subjective memory in older adults. J Gerontol 2004;59B:P4–P6.
  9. Jurgwirth S, Fischer P, Weissgram S, Kirchmeyr W, Bauer P, Tragl KH: Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community. J Am Geriatr Soc 2004;52:263–268.
  10. Flicker C, Ferris SH, Reisberg B: A longitudinal study of cognitive function in elderly persons with subjective memory complaints. J Am Geriatr Soc 1993;41:1029–1032.
  11. Schofield PW, Marder K, Dooneief G, Jacobs D, Sano M, Yaakov P: Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 1997;154:609–615.
  12. Jorm AF, Christensen H, Korten AE, Jacomb PA, Henderson AS: Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7–8 years. Psychol Med 2001;31:441–449.
  13. Schmand B, Jonker C, Geerlings MI, Lindeboom J: Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry 1997;171:373–376.
  14. Reisberg B, Sclan SG, Franssen EH, et al: Clinical stages of normal aging and Alzheimer’s disease: the GDS staging system. Neurosci Res Commun 1993;13(suppl 1): 551–554.
  15. Reisberg B, Ferris SH: The Brief Cognitive Rating Scale (BCRS). Psychopharmacol Bull 1988;24:629–636.
  16. Folstein M: The Mini-Mental State Examination; in Crook T, Ferris SH, Bartus R (eds): Assessment in Geriatric Psychopharmacology. New Canaan, Powley Associates, 1983, pp 47–51.
  17. Cockrell JR, Folstein MF: Mini-mental state examination (MMSE). Psychopharmacol Bull 1988;24:689–692.
  18. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  19. Bech P, Kastrup M, Rafaelsen OJ: Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl 1986;326:1–37.
  20. Gilbert JG, Levee RF, Catalano FL: A preliminary report on a new memory scale. Percept Mot Skills 1968;27:277–278.
  21. De Santi S, Li J, Reisberg B, et al: How good are single and multiple domains for characterizing MCI patients at risk for AD? Alzheimers Dement 2005;1:S81.

    External Resources

  22. Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006–1009.
  23. Reisberg B, Franssen EH, Bobinski M, et al: Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer’s disease. Int Psychogeriatr 1996;8:159–193.
  24. Crook TH, Feher EP, Larrabee GJ: Assessment of memory complaint in age-associated memory impairment: the MAC-Q. Int Psychogeriatr 1992;4[:]165–176.
  25. Edwards ER, Lindquist K, Yaffe K: Clinical profile and course of cognitively normal patients evaluated in memory disorders clinics. Neurology 2004;62:1639–1642.
  26. Schmand B, Jonker C, Hooijer C, Lindeboom J: Subjective memory complaints may announce dementia. Neurology 1996;46:121–125.
  27. St John P, Montgomery P: Are cognitively intact seniors with subjective memory loss more likely to develop dementia? Int J Geriatr Psychiatry 2002;17:814–820.
  28. Dik MG, Jonker C, Comijs HC, et al: Memory complaints and APO-E4 accelerate cognitive decline in cognitively normal elderly. Neurology 2001;57:2217–2222.
  29. Reisberg B, Ferris S, de Leon MJ, Torossian C, Kadiyala S, Zhu W: Subjective cognitive impairment: the pre-mild cognitive impairment stage of brain degeneration – longitudinal outcome after a mean of 7 years follow-up. Neuropsychopharmacology 2005;30(suppl 1):s81.
  30. Gauthier S, Reisberg B, Zaudig M, et al: Mild cognitive impairment. Lancet 2006;367:1262–1270.
  31. Lopez OL, Jagust WJ, Dulberg C, et al: Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003;60:1394–1399.
  32. Agbayewa O: Earlier psychiatric morbidity in patients with Alzheimer’s disease. J Am Geriatr Soc 1986;34:561–564.
  33. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH: Depressive symptoms, sex and risk for Alzheimer’s disease. Ann Neurol 2005;57:381–387.
  34. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D: Depression as a risk factor for Alzheimer’s disease: the MIRAGE study. Arch Neurol 2003;60:753–759.
  35. Dufouil C, Fuhrer R, Dartigues JF, Alpertivitch JS: Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol 1996;144:634–641.
  36. Squire LR, Zouzounis JA: Self-ratings of memory dysfunction: different findings in depression and amnesia. J Clin Exp Neuropsychol 1988;10:727–738.
  37. Larrieu S, Letenneur L, Orgogozo JM: Incidence and outcome of mild cognitive impairment: a population-based prospective cohort. Neurology 2002;59:1594–1599.
  38. Ganguli M, Dodge HH, Shen C, DeKosky ST: Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004;63:115–121.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50